CA
FMTX

Cliff Asness’s Forma Therapeutics Holdings, Inc. Common Stock FMTX Stock Holding History

Cliff Asness’s Portfolio FMTX Stock Details FMTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-34,037
Closed -$235K – 2379
2022
Q2 		$235K Buy
+34,037
New +$239K ﹤0.01% 1942

Other funds holding FMTX

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.26B AUM 81.38% 1-Year Est. Return
WIC
Water Island Capital New York $1.08B AUM 105.75% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
FTCM
First Trust Capital Management Chicago, Illinois $1.72B AUM 70.66% 1-Year Est. Return

Cliff Asness's FMTX Position: Q3 2022 in Review

Cliff Asness sold out of Forma Therapeutics Holdings, Inc. Common Stock (FMTX) in Q3 2022, closing a stake of 34,037 shares — an estimated $235K sold.

Cliff Asness first reported a position in FMTX in Q2 2022 and held it in 1 quarter. The position peaked at $235K in Q2 2022. 139 funds tracked by Wall St. Rank hold FMTX as of Q3 2022.

  • Cliff Asness reported no remaining Forma Therapeutics Holdings, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Cliff Asness sold 34,037 Forma Therapeutics Holdings, Inc. Common Stock shares in Q3 2022, an estimated $235K.
  • Cliff Asness first reported a position in Forma Therapeutics Holdings, Inc. Common Stock in Q2 2022 and held it in 1 quarter.
  • Cliff Asness's Forma Therapeutics Holdings, Inc. Common Stock position peaked at $235K in Q2 2022.
  • 139 funds tracked by Wall St. Rank held Forma Therapeutics Holdings, Inc. Common Stock as of Q3 2022.

Based on AQR Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.